Category:

Dexcom Begins New Chapter as Jake Leach Takes Over as CEO

Dexcom has entered a new phase of leadership as Jake Leach assumed his expanded role as President and Chief Executive Officer on January 1. Leach succeeded long-time CEO Kevin Sayer, who led the company for a decade and oversaw significant revenue growth and major advances in continuous glucose monitoring technology. Leach joined Dexcom more than 20 years ago as an engineer and later served as Chief Operating Officer, where he helped scale operations to meet rising demand…

Posted On : Published By : jcarlos
Category:

Dr. Linda Genen Joins GeneDx to Accelerate Genomic-First Care Integration

GeneDx announced the appointment of Dr. Linda Genen, MD, MPH, as Chief Medical Officer to advance the company’s mission of delivering earlier answers and improved health outcomes through genomic insights. In her role, Genen will oversee Medical and Clinical Affairs, lead clinical strategy, and promote the adoption of genomic medicine across health systems, payers, policymakers, and the broader medical community. She will also guide real-world evidence initiatives, payer engagement, and collaborate with GeneDx’s innovation, commercial, and policy teams to expand genomic-first care…

Posted On : Published By : jcarlos